相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
- 库存:
货期:电询
- 供应商:
MedChemExpress LLC
- CAS号:
229639-54-7
- 规格:
电询
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
R-(+)-Mono-desmethylsibutramine
CAS No. : 229639-54-7
MCE 国际站:R-(+)-Mono-desmethylsibutramine
产品活性:R-(+)-Mono-desmethylsibutramine是Mono-desmethylsibutramine的R对映体。
研究领域:Others
作用靶点:Others
In Vitro: Sibutramine, a monoamine reuptake inhibitor, is used as a racemate, for the treatment of obesity. It is converted in vivo mainly to two desmethyl active metabolites, mono-desmethylsibutramine (MDS) and di-desmethylsibutramine (DDS) .
相关产品:Digitonin | 5-Ph-IAA | FLAG peptide | Tocofersolan | Monocrotaline | Lactate sodium | TCEP hydrochloride | 3X FLAG peptide | DPPH | Pertussis Toxin | Pronase E (Activity ≥ 7000 U/g) | O-Propargyl-Puromycin | NMDI14 | Phytohemagglutinin | MYLS22 | Hyaluronidase | Biotinyl tyramide | Kifunensine | Human IgG1 kappa, Isotype Control | 4-Azido-L-phenylalanine | 6-Aminonicotinamide | Ammonium tetrathiomolybdate(VI) | OVA Peptide(257-264) TFA | Alkyne-phenol | Lauryl maltose neopentyl glycol | SHIN1 | CHAPS | Cytosporone B
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验MHC-I 单体的Mono Q柱层析 【试剂及材料】 1、材料 (1)快速蛋白液相色谱装置(FPLC) (2)层析柱(Mono Q HR5/5 Column) (3)离心过滤器(ultrafree-15,ultrafree-4) (4)50ml 聚丙烯离心管 (5)IEC GP8R 离心机 2、试剂 (1)Buffer A :20mM Tris(PH8.0) (2)Buffer B :20
Electrophysiological Methods for Investigating Inhibitory Synaptic Plasticity
because it forms pores in the neuronal membrane that are permeable to monovalent cations and small uncharged molecules, but not to Cl− . Preserving the neuronal Cl− gradient is essential for recording native inhibitory GABAA receptor (GABAA R) currents
Nature 重磅:新发脑胶质瘤疫苗初见成效,瞄准肿瘤「阿喀琉斯之踵」
,发挥抗肿瘤效应。该成果以 A vaccine targeting mutant IDH1 in newly diagnosed glioma 为题发表在最新的 Nature 上 [2]。 图片来源:Nature 研究内容:这是一项靶向 IDH1R132H 的多肽疫苗治疗 III-IV 级(WHO 分级)胶质瘤的安全性、耐受性和免疫原性的多中心 I 期临床研究(NCT02454634)。研究人员筛选了 44 名患者,其中 32 名患者入组参与了临床试验并接受了 IDH-vac 治疗。在这 32 名
技术资料暂无技术资料 索取技术资料

















